CoChat
Sign Up
Cited by 286Antifungal resistance and susceptibilityImmunodeficiency and Autoimmune DisordersImmune Response and Inflammation

Dectin-1 Y238X polymorphism associates with susceptibility to invasive aspergillosis in hematopoietic transplantation through impairment of both recipient- and donor-dependent mechanisms of antifungal immunity

Open access
Cunha, Cristina, Di Ianni, Mauro, Bozza, Silvia, Giovannini, Gloria, Zagarella, Silvia, Zelante, Teresa, D'Angelo, Carmen, Pierini, Antonio +10 more·2010·Blood
DOI 10.1182/blood-2010-04-279307
Open this paper in CoChat — free accountOpen PDF

Abstract

The C-type lectin receptor Dectin-1 plays a pivotal role in antifungal immunity. In this study, the recently characterized human DECTIN1 Y238X early stop codon polymorphism leading to diminished Dectin-1 receptor activity was studied in relation to invasive aspergillosis susceptibility and severity in patients receiving hematopoietic stem cell transplantation. We found that the presence of the DECTIN1 Y238X polymorphism in either donors or recipients of hematopoietic stem cell transplantation increased susceptibility to aspergillosis, with the risk being highest when the polymorphism was present simultaneously in both donors and recipients (adjusted hazard ratio = 3.9; P = .005). Functionally, the Y238X polymorphism impaired the production of interferon-γ and interleukin-10 (IL-10), in addition to IL-1β, IL-6, and IL-17A, by human peripheral mononuclear cells and Dectin-1 on human epithelial cells contributed to fungal recognition. Mechanistically, studies on preclinical models of infection in intact or bone marrow-transplanted Dectin-1 knockout mice revealed that protection from infection requires a distinct, yet complementary, role of both donor and recipient Dectin-1. This study discloses Dectin-1 deficiency as a novel susceptibility factor for aspergillosis in high-risk patients and identifies a previously unsuspected role for Dectin-1 in antifungal immunity that is the ability to control both resistance and tolerance to the fungus contingent on hematopoietic/nonhematopoietic compartmentalization.

Integrity signals

Registry

Crossref · 10.1182/blood-2010-04-279307

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

The text we found for this paper looks like another document, so its claims and self-check weren’t run. The registry and citation checks still apply.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The text we found for this paper looks like another document, so the self-check wasn’t run.

Cites

Flagged first, then by citations

Research works printed but not linked: 49

  1. Segal BH, Walsh TJ. Current approaches to diagnosis and treatment of 1 invasive aspergillosis. Am J Respir Crit Care Med 2006; 173 : 707 -717.
  2. Stergiopoulou T, Meletiadis J, Roilides E, 3 et al . Host-dependent patterns of tissue injury in invasive pulmonary aspergillosis. Am J Clin Pathol 2007; 127 : 349 -355.
  3. Gravelat FN, Doedt T, Chiang LY, 4 et al . In vivo analysis of Aspergillus fumigatus developmental gene expression determined by real-time reverse transcription-PCR. Infect Immun 2008; 76 : 3632 -3639.
  4. Garcia-Vidal C, Upton A, Kirby KA, Marr KA. Epidemiology of 5 invasive mold infections in allogeneic stem cell transplant recipients: biological risk factors for infection according to time after transplan- tation. Clin Infect Dis 2008; 47 : 1041 -1050.
  5. Denning DW, Follansbee SE, Scolaro M, 6 et al . Pulmonary aspergil- losis in the acquired immunodefi ciency syndrome. N Engl J Med 1991; 324 : 654 -662.
  6. Cenci E, Mencacci A, Fe d ' Ostiani C, 7 et al . Cytokine-and T helper- dependent lung mucosal immunity in mice with invasive pulmonary aspergillosis. J Infect Dis 1998; 178 : 1750 -1760.
  7. Roilides E, Katsifa H, Walsh TJ. Pulmonary host defences against 8 Aspergillus fumigatus . Res Immunol 1998; 149 : 454 -465; discussion 523 -524.
  8. Romani L, Fallarino F, De Luca A, 9 et al . Defective tryptophan catab- olism underlies infl ammation in mouse chronic granulomatous dis- ease. Nature 2008; 451 : 211 -215.
  9. Hollingsworth JW, Chen BJ, Brass DM, 10 et al . The critical role of hematopoietic cells in lipopolysaccharide-induced airway infl amma- tion. Am J Respir Crit Care Med 2005; 171 : 806 -813.
  10. Carvalho A, Cunha C, Pasqualotto AC, 11 et al . Genetic variability of innate immunity impacts human susceptibility to fungal diseases. Int J Infect Dis 2010; 14 : e460-8.
  11. Romani L. Immunity to fungal infections. 12 Nat Rev Immunol 2004; 4 : 1 -23. Latge JP. 13 Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev 1999; 12 : 310 -350.
  12. Bellocchio S, Moretti S, Perruccio K, 14 et al . TLRs govern neutrophil activity in aspergillosis. J Immunol 2004; 173 : 7406 -7415.
  13. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate 15 immunity. Cell 2006; 124 : 783 -801.
  14. Bellocchio S, Montagnoli C, Bozza S, 16 et al . The contribution of the Toll-like/IL-1 receptor superfamily to innate and adaptive immunity to fungal pathogens in vivo . J Immunol 2004; 172 : 3059 -3069.
  15. Bretz C, Gersuk G, Knoblaugh S, 17 et al . MyD88 signaling contributes to early pulmonary responses to Aspergillus fumigatus . Infect Immun 2008; 76 : 952 -958.
  16. Chignard M, Balloy V, Sallenave JM, Si-Tahar M. Role of Toll-like 18 receptors in lung innate defense against invasive aspergillosis. Distinct impact in immunocompetent and immunocompromized hosts. Clin Immunol 2007; 124 : 238 -243.
  17. Ramirez-Ortiz ZG, Specht CA, Wang JP, 19 et al . Toll-like receptor 9-dependent immune activation by unmethylated CpG motifs in Aspergillus fumigatus DNA. Infect Immun 2008; 76 : 2123 -2129.
  18. Chai LY, Kullberg BJ, Vonk AG, 20 et al . Modulation of Toll-like recep- tor 2 (TLR2) and TLR4 responses by Aspergillus fumigatus . Infect Immun 2009; 77 : 2184 -2192.
  19. Ferwerda G, Meyer-Wentrup F, Kullberg BJ, Netea MG, Adema GJ. 22 Dectin-1 synergizes with TLR2 and TLR4 for cytokine production in human primary monocytes and macrophages. Cell Microbiol 2008; 10 : 2058 -2066. Med Mycol Downloaded from informahealthcare.com by Universita Studi di Perugia on 08/23/10
  20. Garantziotis S, Hollingsworth JW, Zaas AK, Schwartz DA. The effect 23 of toll-like receptors and toll-like receptor genetics in human disease. Annu Rev Med 2008; 59 : 343 -359.
  21. Lasker MV, Nair SK. Intracellular TLR signaling: a structural 24 perspective on human disease. J Immunol 2006; 177 : 11 -16.
  22. Rallabhandi P, Bell J, Boukhvalova MS, 25 et al . Analysis of TLR4 poly- morphic variants: new insights into TLR4/MD-2/CD14 stoichiometry, structure, and signaling. J Immunol 2006; 177 : 322 -332.
  23. Arbour NC, Lorenz E, Schutte BC, 26 et al . TLR4 mutations are associ- ated with endotoxin hyporesponsiveness in humans. Nat Genet 2000; 25 : 187 -191.
  24. Michel O, LeVan TD, Stern D, 27 et al . Systemic responsiveness to lipopolysaccharide and polymorphisms in the toll-like receptor 4 gene in human beings. J Allergy Clin Immunol 2003; 112 : 923 -929.
  25. Kiechl S, Lorenz E, Reindl M, 32 et al . Toll-like receptor 4 polymor- phisms and atherogenesis. N Engl J Med 2002; 347 : 185 -192.
  26. Romani L, Puccetti P. Controlling pathogenic infl ammation to fungi. 33 Expert Rev Anti Infect Ther 2007; 5 : 1007 -1017.
  27. Ferwerda B, McCall MB, Alonso S, 34 et al . TLR4 polymorphisms, infectious diseases, and evolutionary pressure during migration of modern humans. Proc Natl Acad Sci USA 2007; 104 : 16645 -16650.
  28. Ramaprakash H, Ito T, Standiford TJ, Kunkel SL, Hogaboam CM. 35 Toll-like receptor 9 modulates immune responses to Aspergillus fumigatus conidia in immunodefi cient and allergic mice. Infect Immun 2009; 77 : 108 -119.
  29. Hurst J, von Landenberg P. Toll-like receptors and autoimmunity. 36 Autoimmun Rev 2008; 7 : 204 -208.
  30. Langrish CL, Chen Y, Blumenschein WM, 38 et al . IL-23 drives a pathogenic T cell population that induces autoimmune infl ammation. J Exp Med 2005; 201 : 233 -240.
  31. Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and Th17 Cells. 39 Annu Rev Immunol 2009; 27 : 485 -517.
  32. Dong C. Diversifi cation of T-helper-cell lineages: fi nding the family 40 root of IL-17-producing cells. Nat Rev Immunol 2006; 6 : 329 -333.
  33. Happel KI, Dubin PJ, Zheng M, 41 et al . Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae. J Exp Med 2005; 202 : 761 -769.
  34. Zelante T, De Luca A, Bonifazi P, 42 et al . IL-23 and the Th17 pathway promote infl ammation and impair antifungal immune resistance. Eur J Immunol 2007; 37 : 2695 -2706.
  35. Smith E, Zarbock A, Stark MA, 43 et al . IL-23 is required for neutrophil homeostasis in normal and neutrophilic mice. J Immunol 2007; 179 : 8274 -8279.
  36. D'Angelo C, De Luca A, Zelante T, 44 et al . Exogenous pentraxin 3 restores antifungal resistance and restrains infl ammation in murine chronic granulomatous disease. J Immunol 2009; 183 : 4609 -4618.
  37. Mencacci A, Spaccapelo R, Del Sero G, 46 et al . CD4 ϩ T-helper-cell responses in mice with low-level Candida albicans infection. Infect Immun 1996; 64 : 4907 -4914.
  38. Conti HR, Shen F, Nayyar N, 47 et al . Th17 cells and IL-17 receptor sig- naling are essential for mucosal host defense against oral candidiasis. J Exp Med 2009; 206 : 299 -311.
  39. Huang W, Na L, Fidel PL, Schwarzenberger P. Requirement of inter- 48 leukin-17A for systemic anti-Candida albicans host defense in mice. J Infect Dis 2004; 190 : 624 -631.
  40. Zelante T, De Luca A, D ' Angelo C, Moretti S, Romani L. IL-17/Th17 in 49 anti-fungal immunity: what's new? Eur J Immunol 2009; 39 : 645 -648.
  41. Weissinger EM, Dickinson AM. Immunogenomics and proteomics in 50 hematopoietic stem cell transplantation: predicting post-hematopoietic stem cell transplant complications. Cancer Treat Res 2009; 144 : 1 -35.
  42. Duerr RH, Taylor KD, Brant SR, 52 et al . A genome-wide associa- tion study identifi es IL23R as an infl ammatory bowel disease gene. Science 2006; 314 : 1461 -1463.
  43. Cargill M, Schrodi SJ, Chang M, 53 et al . A large-scale genetic associa- tion study confi rms IL12B and leads to the identifi cation of IL23R as psoriasis-risk genes. Am J Hum Genet 2007; 80 : 273 -290.
  44. Elmaagacli AH, Koldehoff M, Landt O, Beelen DW. Relation of an in- 54 terleukin-23 receptor gene polymorphism to graft-versus-host disease after hematopoietic-cell transplantation. Bone Marrow Transplant 2008; 41 : 821 -826.
  45. Kohyama S, Ohno S, Isoda A, 56 et al . IL-23 enhances host defense against vaccinia virus infection via a mechanism partly involving IL-17. J Immunol 2007; 179 : 3917 -3925.
  46. Zaas AK, Liao G, Chien JW, 57 et al . Plasminogen alleles infl uence sus- ceptibility to invasive aspergillosis. PLoS Genet 2008; 4 : e1000101.
  47. Granell M, Urbano-Ispizua A, Suarez B, 59 et al . Mannan-binding lectin pathway defi ciencies and invasive fungal infections following alloge- neic stem cell transplantation. Exp Hematol 2006; 34 : 1435 -1441.
  48. Mezger M, Steffens M, Beyer M, 60 et al . Polymorphisms in the chemokine (C-X-C motif) ligand 10 are associated with invasive aspergillosis after allogeneic stem-cell transplantation and infl uence CXCL10 expression in monocyte-derived dendritic cells. Blood 2008; 111 : 534 -536.
  49. Seo KW, Kim DH, Sohn SK, 61 et al . Protective role of interleukin-10 promoter gene polymorphism in the pathogenesis of invasive pul- monary aspergillosis after allogeneic stem cell transplantation. Bone Marrow Transplant 2005; 36 : 1089 -1095.

Cited by

Sorted by citations

Related

Authors
Cunha, C., Di Ianni, M., Bozza, S., Giovannini, G., Zagarella, S., Zelante, T., D'Angelo, C., Pierini, A., Pitzurra, L., Falzetti, F., Carotti, A., Perruccio, K., Latgé, J.-P., Rodrigues, F., Velardi, A., Aversa, F., Romani, L., & Carvalho, A.
Affiliations
  • University of Perugia (IT)
  • Division of Hematology and Clinical Immunology, Department of Clinical and Experimental Medicine, University of Perugia, Perugia, Italy;
  • Institut Pasteur (FR)
  • University of Minho (PT)
ORCID
Venue
Blood
Publisher
American Society of Hematology
Published
2010-12-09
Volume
116
Issue
24
Pages
5394-5402
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
DOI
10.1182/blood-2010-04-279307
OpenAlex
W2101233099
Cited by
286
References
44
Citations by year
2026: 8 · 2025: 9 · 2024: 15 · 2023: 9 · 2022: 16 · 2021: 23 · 2020: 16 · 2019: 15 · 2018: 17 · 2017: 18 · 2016: 23 · 2015: 21 · 2014: 20 · 2013: 19 · 2012: 29
FWCI
15.70
Type
journal article
Language
en
Open access
Locations
  • Blood (publishedVersion)
  • PubMed (publishedVersion)
  • Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, other-oa)
  • Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, cc-by-nc-nd)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
Keywords
Dectin-1, invasive aspergillosis, hematopoietic stem cell transplantation, antifungal immunity, C-type lectin receptors, interferon-gamma, IL-10, IL-17A, fungal recognition, bone marrow transplantation
MeSH terms
Dectin-1, Adolescent, Adult, Aged, Animals, Aspergillosis, Child, Disease Susceptibility, Epithelial Cells, Female, Fungi, Humans, Leukocytes, Mononuclear, Male, Membrane Proteins, Middle Aged, Nerve Tissue Proteins, Polymorphism, Genetic, Cytokines, Mice, Knockout, Hematopoietic Stem Cell Transplantation, Lectins, C-Type, Mice, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review